(19)
(11) EP 1 158 981 A1

(12)

(43) Date of publication:
05.12.2001 Bulletin 2001/49

(21) Application number: 00907654.8

(22) Date of filing: 02.03.2000
(51) International Patent Classification (IPC)7A61K 31/4468
(86) International application number:
PCT/EP0001/725
(87) International publication number:
WO 0051/606 (08.09.2000 Gazette 2000/36)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 04.03.1999 GB 9904935

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • BATENHORST, Randal, L.,Glaxo Wellcome Inc.
    Research Triangle Park, NC 27709 (US)
  • FOX, Anthony, William
    Rancho La Costa, CA 92009 (US)
  • JAMERSON, Brenda, Diane,Glaxo Wellcome Inc.
    Research Triangle Park, NC 27709 (US)

(74) Representative: Reeves, Julie Frances et al
GlaxoSmithKline,Two New Horizons Court
Brentford,Middlesex TW8 9EP
Brentford,Middlesex TW8 9EP (GB)

   


(54) USE OF REMIFENTANYL FOR REDUCING BLOOD PRESSURE